CancerTYPE ID® publications and scientific presentations
Analytical Validity
Clinical Validity
Clinical Utility
Health Economics
Review Documents
Analytical Validity
Performance and Clinical Evaluation of the 92-Gene Real-Time PCR Assay for Tumor Classification.
Mark G. Erlander, Xiao-Jun Ma, Nicole C Kesty, Lei Bao, Ranelle Salunga, Catherine A. Schnabel. J Mol Diagn 2011 September 2011, Vol. 13, No. 5. 492-503.
Molecular Classification of Human Cancers Using a 92-Gene Real-Time Quantitative Polymerase Chain Reaction Assay
Ma, XJ et. al. Archives of Pathology & Laboratory Medicine. April 2006, Vol. 130, No. 4. 465-473.
Molecular Classification of Tumor of Unknown Origin by Gene-Expression from Fixed Paraffin Embedded Tissue
Erlander, MG et al. American Society of Clinical Oncology, June 2004.
Clinical Validity
Performance and Clinical Evaluation of the 92-Gene Real-Time PCR Assay for Tumor Classification.
Mark G. Erlander, Xiao-Jun Ma, Nicole C Kesty, Lei Bao, Ranelle Salunga, Catherine A. Schnabel. J Mol Diagn 2011 September 2011, Vol. 13, No. 5. 492-503.
Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction
Greco, FA et al. The Oncologist. 2010;15:500-506.
Unknown Primary Cancer (UPC): Accuracy of Tissue of Origin Prediction by Molecular Profiling
Greco, FA et al. American Society of Clinical Oncology Annual Meeting Poster Presentation, May/June, 2009.
Molecular Classification of Human Cancers Using a 92-Gene Real-Time Quantitative Polymerase Chain Reaction Assay
Ma, XJ et. al. Archives of Pathology & Laboratory Medicine. April 2006, Vol. 130, No. 4. 465-473.
Clinical Utility
A Retrospective Study of Treatment Outcomes in Patients with Carcinoma of Unknown Primary Site and a Colorectal Cancer Molecular Profile
John D. Hainsworth, MD, Catherine A. Schnabel, PhD, Mark G. Erlander, PhD, David W. Haines III, BS, F. Anthony Greco, MD. Clin Colorectal Cancer. 2011 (10.1016/j.clcc.2011.08.001).
Diagnostic utility of molecular profiling for cancers of uncertain primary.
M. Laouri, B. Schroeder, E. Chen, M. G. Erlander, C. Schnabel. J Clin Oncol 29: 2011 (suppl; abstr e21103).
Molecular tumor classification using a 92-gene assay in the differential diagnosis of squamous cell lung cancer
McGee R, et al. Community Oncol. 2011; 8:123-131.
Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction
Greco, FA et al. The Oncologist. 2010;15:500-506.
Evolving Understanding and Current Management of Patients with Cancer of Unknown Primary Site
Greco, FA. Commun Oncol. 2010; 7:183-188.
Treatment of Carcinoma of Unknown Primary Site (CUP) Directed by Molecular Profiling Diagnosis: A Prospective, Phase II Trial
Hainsworth, JD et al. American Society of Clinical Oncology Annual Meeting Poster Presentation, June, 2010.
Unknown Primary Cancer (UPC): Accuracy of Tissue of Origin Prediction by Molecular Profiling
Greco, FA et al. American Society of Clinical Oncology Annual Meeting Poster Presentation, May/June, 2009.
Health Economics
Psychosocial Aspects of Treating Patients with Cancer of Unknown Primary (CUP): A Survey of Oncology Social Workers
McCormick, BK; Erlander, MG. Association of Oncology Social Work Annual Conference Poster Presentation, May, 2009.
Review Documents
Molecular Classification of Cancers of Unknown Primary Site
Greco, FA; Erlander, MG. Mol Diagn Ther. 2009 Dec 1;13(6):367-73.
Molecular Classification of Unknown Primary Cancer
Bender, RA; Erlander, MG. Sem Oncol. 2009;36:38-43.
Gene-Expression Profiling and Cancer of an Unknown Primary Origin
Acevedo, P; Castro, V. Commun Oncol. 2008;5:590-592.
Molecular Classification of Cancer: Implications for Carcinoma of Unknown Primary
Erlander, MG. United States and Canadian Academy of Pathology meeting, AMP companion meeting, March 25, 2007.
+1 (877) 886-6739 client services
